### 21. is concerned about the risks caused by the serious delay in completing the third pillar of the banking union; welcomes the ecb’s long-standing support of the establishment of a fully fledged european deposit insurance scheme (edis); ### 21. is concerned about the risks caused by the serious delay in completing the third pillar of the banking union; welcomes the ecb’s long-standing support of the establishment of a fully fledged european deposit insurance scheme (edis) that would complete the banking union , ensure depositors’ protection , support the confidence of savers and safeguard financial stability;


### 22. welcomes the ecb’s decision to launch a 24-month investigation phase of a digital euro project; calls on the ecb to effectively address the expectations and concerns raised during the public consultation on a digital euro; ### 22. welcomes the ecb’s decision to launch a 24-month investigation phase of a digital euro project; calls on the ecb to effectively address the expectations and concerns raised during the public consultation on a digital euro , such as privacy , security , the ability to pay across the euro area , no additional costs and offline usability; notes that this investigation phase will not prejudge any decision on the possible issuance of a digital euro;


### 23. welcomes the continuous efforts of the ecb to strengthen its response and recovery capabilities in the event of cyberattacks; ### 23. stresses that the financial sector is undergoing considerable transformation driven by innovation and digitalisation; underlines that this transformation poses increased risks for external disruptions such as cyberattacks; welcomes the continuous efforts of the ecb to strengthen its response and recovery capabilities in the event of cyberattacks; reiterates its concern regarding the incidents that seriously affected target2 and target2-securities in 2020; welcomes the independent review of these incidents and notes that a number of findings were rated with ‘high’ severity; welcomes the eurosystem’s acceptance of the general conclusions and its commitment to implement the recommendations of the review; calls on the ecb to further enhance its efforts in the field of cybersecurity and to continue to promote the cyber resilience of financial market infrastructures;


### 24. calls on the ecb to step up its monitoring of the development of crypto-currencies and the related risks in terms of cybersecurity and money laundering; ### 24. calls on the ecb to step up its monitoring of the development of crypto-currencies and the related risks in terms of cybersecurity and money laundering; calls on the ecb to ensure an adequate balance between financial innovation , including in the fintech area , and financial stability; takes note of ecb’s intention to develop and implement a policy response to mitigate the potential adverse impact of stablecoins on the eu payments and financial landscape while enabling sound initiatives to bring benefits to consumers and businesses;


### 25. welcomes the substantial and detailed feedback provided by the ecb to parliament’s resolution on the 2019 ecb annual report; ### 25. welcomes the substantial and detailed feedback provided by the ecb to parliament’s resolution on the 2019 ecb annual report; calls on the ecb to continue this commitment to accountability and keep on publishing its written feedback to parliament’s resolutions on the ecb annual reports each year;


### 26. stresses the need to further enhance the accountability and transparency arrangements of the ecb; recognises the steps taken by the ecb; repeats its call to launch negotiations on a formal interinstitutional agreement; ### 26. stresses the need to further enhance the accountability and transparency arrangements of the ecb; recognises the steps taken by the ecb , such as the adoption of the single code of conduct for high-level ecb officials and the decision to publish the ethics committee’s opinions addressed to the current members of the executive board , governing council and supervisory board that have been issued since the entry into force of the single code of conduct; repeats its call to launch negotiations on a formal interinstitutional agreement to formalise and go beyond the existing transparency and accountability practices;


### 27. reiterates its call for the ecb to ensure the independence of the members of its audit committee , as well as of its ethics committee; ### 27. reiterates its call for the ecb to ensure the independence of the members of its audit committee , as well as of its ethics committee; urges the ecb to ensure that the ethics committee is not chaired by a former president or other past members of the governing council , nor by anyone liable to conflict of interest; calls on the ecb to require a two-year cooling-off period for its outgoing members after the conclusion of their mandate;


### 28. welcomes the ecb’s new internal whistleblowing framework; calls on the ecb to ensure its integrity and efficiency; ### 28. welcomes the ecb’s new internal whistleblowing framework; calls on the ecb to ensure the integrity and efficiency of the new internal tool in order to facilitate truly simple and secure reporting of potential breaches of professional duties , inappropriate behaviour or other irregularities , and the possibility for whistleblowers and witnesses to be granted effective protection from any kind of retaliation;


### 29. reiterates that the nominations of the executive board members should be prepared carefully and take a gender-balanced approach , with full transparency and together with parliament , in line with the treaties; ### 29. expresses strong concern that only two of the ecb’s executive board are women; reiterates that the nominations of the executive board members should be prepared carefully and take a gender-balanced approach , with full transparency and together with parliament , in line with the treaties; calls on the council to draw up a gender-balanced shortlist for any upcoming vacancies and to share it with parliament , thus allowing it to play a more meaningful advisory role in the appointment process; regrets that no satisfactory progress has been made to date in this regard; reiterates its commitment not to take into account lists of candidates where the gender balance principle has not been respected;


### 30. welcomes the ecb’s new strategy to further improve the gender balance of its staff at all levels; notes the increasing share of women in managerial positions , which , however , remains low; ### 30. notes that , at the end of 2019 , the share of women in all management positions of the ecb rose to 30.3 % and in its senior management positions to 30.8 %; underlines , however , that this share remains considerably low; welcomes , in this regard , the ecb’s new strategy to further improve the gender balance of its staff at all levels , including the objective to fill at least half of new and open positions with women on all levels and the target to increase the share of women at the different levels to between 40 % and 51 % by 2026; calls on the ecb to further incentivise the participation of women and actively promote a gender-balanced representation in all its positions;


### c. whereas the g20/oecd inclusive framework on beps agreed on the key components of a two-pillar reform of the international tax system in order to address the challenges arising from the digitalisation of the economy , including a minimum effective corporate tax rate of 15 %; ### c. whereas the g20/oecd inclusive framework on beps agreed on the key components of a two-pillar reform of the international tax system in order to address the challenges arising from the digitalisation of the economy , including a minimum effective corporate tax rate of 15 %; whereas the result of the final negotiations is weaker than the initial proposal;


### d. whereas withholding taxes can reduce the risk of tax evasion and avoidance , thus remaining a reliable policy tool until the implementation of the above-mentioned agreement by the g20/oecd inclusive framework on beps; ### d. whereas withholding taxes can reduce the risk of tax evasion and avoidance; whereas member states are entitle to have countermeasures to protect their tax base;


### e. whereas complex refund procedures increase the administrative burden for cross-border investments and may create an obstacle to market integration; ### e. whereas complex non-standardized refund procedures increase the administrative burden , making the process lengthy and more prone to fraud;


### f. whereas the interest and royalties directive (ird) and the parent-subsidiary directive (psd) both exempt certain cross-border payments that take place within the eu and are related to interest , royalties and dividends from withholding tax with the aim of eliminating double taxation; whereas negotiations on a revision of the ird have stalled in the council for several years; ### f. whereas the interest and royalties directive (ird) and the parent-subsidiary directive (psd) both exempt specific cross-border payments that take place within the eu for associated companies and are related to interest , royalties and dividends from withholding tax with the aim of eliminating double taxation; whereas negotiations on a revision of the ird have stalled in the council for several years because 7 member states voted against the inclusion of an effective minimum taxation rate;


### g. whereas the cum-ex and cum-cum schemes both involve reclaims of dividend withholding tax to which the beneficiaries were not entitled and are estimated to have imposed a total cost to taxpayers of about eur 55 billion between 2001 and 2012 in the 11 member states concerned; ### g. whereas the cum-ex and cum-cum schemes both involve reclaims of dividend withholding tax to which the beneficiaries were not entitled and are estimated to have imposed a total cost to taxpayers of about eur 55 billion between 2001 and 2012 in the 11 member states concerned; whereas new revelations on october 2021 updated those values to eur 140 billion;


### 1. notes that despite continuous efforts , the system of withholding taxes in the eu has remained largely fragmented , creating loopholes which could be abused to shift profits and barriers to cross-border investments in the single market; ### 1. notes that despite continuous efforts , the system of withholding taxes in the eu has remained largely fragmented , creating loopholes which could be abused to shift profits and allow for fraud schemes;


### 3. welcomes the agreement reached by the g20/oecd inclusive framework on a two-pillar reform , including a global minimum effective tax rate; considers this an important step towards ending the practice of shifting profits to low-tax jurisdictions; regrets the fact that the scope is limited to multinational enterprises with a global consolidated turnover of at least eur 750 million; ### 3. welcomes the agreement reached by the g20/oecd inclusive framework on a two-pillar reform , including a global minimum effective tax rate; considers this an important step towards ending the practice of shifting profits to low-tax jurisdictions; regrets the fact that the final agreement has been weakened as a result of the negotiations and the scope has been limited to multinational enterprises with a global consolidated turnover of at least eur 750 million; in addition , regrets the fact that the minimum tax rate has been set at 15% (while the initial proposal was 21%) , as well as the inclusion of carve-out clauses that lead to a lower effective corporate tax rate and the fact that the principle of taxing profits where the business activity happens is not really respected;


### 4. is pleased that 136 countries and jurisdictions have supported the g20/oecd inclusive framework agreement on a two-pillar reform; regrets the fact that one member state is not part of the inclusive framework; ### 4. is pleased that 136 countries and jurisdictions have supported the g20/oecd inclusive framework agreement on a two-pillar reform; regrets the fact that one member state , cyprus , is not part of the inclusive framework;


### 5. regrets the fact that base erosion and profit shifting are still ongoing and are facilitated by the tax regimes of certain member states; recalls that the commission , in the context of the european semester and the assessment of the national recovery and resilience plans , found that more reforms are needed in order to address aggressive tax planning in six member states , where the absence or limited application of withholding taxes on outbound payments are likely to be misused for aggressive tax planning; ### 5. regrets the fact that base erosion and profit shifting are still ongoing and are facilitated by the tax regimes of certain member states; recalls that the commission , in the context of the european semester and the assessment of the national recovery and resilience plans , found that more reforms are needed in order to address aggressive tax planning in cyprus , hungary , ireland , luxembourg , malta and the netherlands , where the absence or limited application of withholding taxes on outbound payments are likely to be misused for aggressive tax planning;


### 6. calls on the commission and the member states to set up a harmonised withholding tax framework that ensures that all dividend , interest and royalties payments flowing out the eu are taxed at a minimum effective tax rate; ### 6. calls on the commission and the member states to set up a harmonised withholding tax framework that ensures that all dividend , interest and royalties payments flowing out the eu are taxed at a minimum effective tax rate; recalls that recent research3a shows large differences in the application of withholding taxes in eu member-states - the rates can vary between 0 and 35% - and points to the fact that withholding tax rates in tax treaties are often 5 to 10 percentage points lower than the standard rates; deplores , in particular , cyprus , hungary , latvia and malta for not levying withholding taxes on neither dividend , interest or royalties payments and luxembourg , netherlands , norway , sweden for not levying it on interest and royalties;


### 7. recalls the proposal by 10 member states to include an effective minimum tax rate for royalties and interest in the context of the ird; urges the council to swiftly resume and conclude the negotiations on the ird and encourages the inclusion of such a measure in the announced directive for the implementation of pillar ii; ### 7. recalls the proposal by 10 member states to include an effective minimum tax rate for royalties and interest in the context of the ird; stresses that 7 member states voted against it and notes that these votes should be publicly known; urges the council to swiftly resume and conclude the negotiations on the ird and encourages the inclusion of such a measure in the announced directive for the implementation of pillar ii;


### 8. notes that the lack of an effective minimum tax rate on dividend payments to shareholders has triggered a race to the bottom in this field; calls for the adoption of an effective minimum tax rate for dividend payments to shareholders in the eu , thereby reducing harmful tax competition in this realm; ### 8. stresses that the lack of an effective minimum tax rate on dividend payments to shareholders has triggered a race to the bottom in this field; calls for the adoption of an effective minimum tax rate for dividend payments to shareholders in the eu , thereby reducing harmful tax competition in this realm;


### 9. recalls that in october 2018 , an investigation disclosed that 11 member states had lost up to eur 55.2 billion in tax revenue as a result of cum-ex and cum-cum schemes; ### 9. recalls that in october 2018 , an investigation disclosed that 11 member states had lost up to eur 55.2 billion in tax revenue as a result of cum-ex and cum-cum schemes; stresses that a new investigation in october 2021 updated those values to eur 140 billion;


### 12. notes that although directive 2014/107/eu has facilitated the exchange of information , other obstacles to the detection of cum-ex and cum-cum schemes exist , including the timeliness of exchanges , the scope of the exchange of information on capital gains , and the insufficient spontaneous exchange of information; ### 12. stresses that although directive 2014/107/eu has facilitated the exchange of information , other obstacles to the detection of cum-ex and cum-cum schemes exist , including the timeliness of exchanges , the scope of the exchange of information on capital gains , and the insufficient spontaneous exchange of information;


### 14. notes the commission’s intention to put forward a proposal by the end of 2022 establishing a european withholding tax framework for dividend , interest or royalty payments , accompanied by a mechanism for the exchange of information and cooperation among tax administrations; ### 14. welcomes the commission’s intention to put forward a proposal by the end of 2022 establishing a european withholding tax framework for dividend , interest or royalty payments , accompanied by a mechanism for the exchange of information and cooperation among tax administrations;


### 15. encourages the development of a harmonised eu procedure for withholding tax refunds for all member states , thereby addressing the concerns about regulatory discrepancies; ### 15. encourages the development of a harmonised eu procedure for withholding tax refunds for all member states , thereby addressing the concerns about regulatory discrepancies; stresses that the main concern should be to tackle the possibilities of fraud;


### 16. notes that digitalising these procedures and improving cooperation between national tax administrations could reduce the administrative burden and uncertainty in cross-border investments; ### 16. stresses that digitalising these procedures and improving cooperation between national tax administrations can reduce the administrative burden and uncertainty in cross-border investments;


### 17. takes note of the option to establish an eu system for relief at source; highlights that a move towards this type of system cannot be detrimental to the fight against tax abuse; stresses that , in all circumstances , compliance by the destination state with the agreement reached by the g20/oecd inclusive framework must be a prerequisite for relief at source; ### deleted


### (1) in order to accommodate new initiatives of the union in the field of tax transparency , council directive 2011/16/eu21 has been the subject of a series of amendments over the last years. these changes mainly introduced reporting obligations , followed by communication to other member states , related to financial accounts , advance cross-border rulings and advance pricing arrangements , country-by-country reports and reportable cross-border arrangements. in such a way , these amendments extended the scope of the automatic exchange of information. the tax authorities now have a broader set of cooperation tools at their disposal , to detect and tackle forms of tax fraud , tax evasion and tax avoidance. ### (1) in order to accommodate new initiatives of the union in the field of tax transparency , council directive 2011/16/eu21 has been the subject of a series of amendments over the last years. these changes mainly introduced reporting obligations , followed by communication to other member states , related to financial accounts , advance cross-border rulings and advance pricing arrangements , country-by-country reports and reportable cross-border arrangements. in such a way , these amendments extended the scope of the automatic exchange of information. the tax authorities now have a broader set of cooperation tools at their disposal , to detect and tackle forms of tax fraud , tax evasion and tax avoidance , in order to safeguard tax revenues and to ensure fair taxation.


### member states shall inform the commission annually of at least two categories of income and capital mentioned in the first subparagraph with regard to which they communicate information concerning residents of another member state. ### member states shall inform the commission annually of all categories of income and capital mentioned in the first subparagraph with regard to which they communicate information concerning residents of another member state.


### 2. before 1 january 2023 , member states shall inform the commission of at least four categories listed in paragraph 1 in respect of which the competent authority of each member state shall , by automatic exchange , communicate to the competent authority of any other member state , information concerning residents in that other member state. the information shall concern taxable periods starting on or after 1 january 2024. ### 2. before 1 january 2023 , member states shall inform the commission of all categories listed in paragraph 1 in respect of which the competent authority of each member state shall , by automatic exchange , communicate to the competent authority of any other member state , information concerning residents in that other member state. the information shall concern taxable periods starting on or after 1 january 2024.


### paragraph 2 is deleted. ### deleted


### 7. the commission shall develop and provide technical and logistical support for a secure central interface on administrative cooperation in the field of taxation where member states communicate with the use of standard forms pursuant to article 20(1) and (3). the competent authorities of all member states shall have access to that interface. for the purpose of collecting statistics , the commission shall have access to information about the exchanges recorded to the interface and which can be extracted automatically. the access by the commission shall be without prejudice to the obligation of member states to provide statistics on exchanges of information in accordance with article 23(4). ### 7. the commission shall develop and provide all the necessary technical and logistical support for a secure central interface on administrative cooperation in the field of taxation where member states communicate with the use of standard forms pursuant to article 20(1) and (3). the competent authorities of all member states shall have access to that interface. for the purpose of collecting statistics , the commission shall have access to information about the exchanges recorded to the interface and which can be extracted automatically. the access by the commission shall be without prejudice to the obligation of member states to provide statistics on exchanges of information in accordance with article 23(4).


### 2. member states shall examine and evaluate , in their jurisdiction , the effectiveness of administrative cooperation in accordance with this directive in combating tax evasion and tax avoidance and shall communicate annually the results of their evaluation to the commission.. ### 2. member states shall examine and evaluate , in their jurisdiction , the effectiveness of administrative cooperation in accordance with this directive in combating tax evasion and tax avoidance and shall communicate annually the results of their evaluation to the commission. these annual reports shall be made public.


### reports and documents produced by the commission , referred to in the first subparagraph , may be used by the member states only for analytical purposes , and shall not be published or made available to any other person or body without the express agreement of the commission. ### reports and documents produced by the commission , referred to in the first subparagraph , may be used by the member states and be accessible to all interested parties and subsequently be public.


### member states shall lay down the rules on penalties applicable to infringements of national provisions adopted pursuant to this directive and concerning articles 8aa , 8ab and 8ac , and shall take all measures necessary to ensure that they are implemented. the penalties provided for shall be effective , proportionate and dissuasive.. ### member states shall lay down the rules on penalties applicable to infringements of national provisions adopted pursuant to this directive and concerning articles 8aa , 8ab and 8ac , and shall take all measures necessary to ensure that they are implemented. the penalties provided for shall be effective , proportionate and dissuasive. these penalties shall include financial penalties , exclusion from public contracts and , in extreme and repeated cases , the revoking of the business licence of the platform operator.


### 1. five years from the entry into application of this regulation , at the latest , esma shall present a report to the commission on: ### 1. two years from the entry into application of this regulation , at the latest , esma shall present a report to the commission on:


### 2. based on the report referred to in paragraph 1 , the commission shall present a report to the european parliament and council including a cost-benefit analysis on whether the regime for dlt market infrastructures under this regulation should be: ### 2. based on the report referred to in paragraph 1 , the commission shall present a report to the european parliament and council showing how it intends to incorporate the lessons learned into existing legislation.


### extended for another period; ### deleted


### extended to other types of financial instruments that can be issued , recorded , transferred or stored on a dlt; ### deleted


### amended; ### deleted


### made permanent with or without amendment; or ### deleted


### terminated. ### deleted


### in its report , the commission may propose any appropriate modifications to the union framework on financial services legislation or harmonisation of national laws that would facilitate the use of distributed ledger technology in the financial sector as well as any measures needed to bridge the transition of dlt market infrastructures out of the pilot regime. ### deleted


### a. whereas , with less than seven years to go until the deadline for the implementation of the 2030 agenda , the new geopolitical landscape and the multiple crises in various areas have hindered the achievement of the sdgs; whereas the 2030 agenda and the 17 sdgs are key to addressing the current challenges and reorienting the global compass towards a socially and environmentally just transition that leaves no one behind; ### a. whereas , with less than seven years to go until the deadline for the implementation of the 2030 agenda , the new geopolitical landscape and the multiple crises in various areas have further hindered the achievement of the sdgs; whereas collective action on a new scale is urgently needed to respond to poverty that is ruining hundreds of millions of lives and to respond to the unprecedented threats to the habitability of our planet posed by the interlinked climate and biodiversity crises; whereas the 2030 agenda and the 17 sdgs are key to addressing the current challenges and reorienting the global compass towards a socially and environmentally just transition that leaves no one behind;


### 1. stresses its commitment to the 2030 agenda , especially in light of the new geopolitical landscape and the ongoing climate , biodiversity and health crises; warns against further polarisation in the distribution of wealth and income , which would lead to increased inequality and poverty; highlights , against this backdrop , the importance of the sdgs , which provide a universal compass for people’s prosperity and to protect the planet; recalls that a pledge to leave no one behind lies at the heart of the 2030 agenda and that the achievement of the sdgs should benefit all countries , people and segments of society; ### 1. stresses its commitment to the 2030 agenda and the 17 sustainable development goals with their 169 accompanying measurable targets , especially in light of the new deteriorating geopolitical landscape and the ongoing climate , biodiversity and health crises; warns against further polarisation in the distribution of wealth and income , which would lead to increasing levels of inequality and poverty ; highlights , against this backdrop , the importance of the sdgs , which provide the only evidence-based universal policy roadmap for people’s prosperity , protecting the planet and averting the climate crisis; recalls that the pledge to leave no one behind lies at the heart of the 2030 agenda and that the achievement of the sdgs should benefit all countries , people and segments of society;


### 2. highlights the fact that , at the halfway point in the 2030 agenda timeline , eu leadership in the global implementation of the sdgs remains crucial; underlines that 2023 offers a unique opportunity to gather momentum and undertake the urgent transformative action required to place our societies firmly on course to achieve the sdgs; warns that the consequences of inaction in this crucial year would primarily be borne by the most vulnerable people; ### 2. highlights the fact that , at the halfway point in the 2030 agenda timeline , eu leadership in the global implementation of the sdgs remains crucial and must be further credibly demonstrated; underlines that 2023 offers a unique opportunity to gather momentum and undertake the urgent transformative action required to place our societies firmly on course to achieve the sdgs; warns that the consequences of inaction in this crucial year would primarily be borne by the most vulnerable people;


### 7. calls on the commission to continue integrating the sdgs into the european semester and to use the country-specific recommendations to systematically measure member states’ progress and set out concrete proposals for improvement; ### 7. calls on the commission to continue integrating the sdgs into the european semester as its compass and to use the country-specific recommendations to systematically measure member states’ progress and set out concrete proposals for improvement , including recommendations for country-specific sdg targets ; suggests that reporting on the implementation of the sdgs should be an opportunity to streamline the european semester , notably in country reports and national reform programmes;


### 8. stresses parliament’s important role in promoting the sdgs’ implementation through european policies and heightening the goals’ visibility in public discourse; underlines that coordination within and between the eu institutions is essential in order to ensure the eu’s leadership and increase the effectiveness of its efforts to implement the 2030 agenda; ### 8. stresses parliament’s important role in promoting the sdgs’ implementation through european policies and heightening the goals’ visibility in public discourse; calls , to this end , on its committees to further integrate sdg considerations in their legislative and non-legislative work; welcomes the efforts made by the parliament’s sdg alliance; encourages the parliament’s general secretariat to produce a parliament sdg review to fully assess its contribution to the achievement of the goals , following similar commitments by other union institutions; underlines that coordination within and between the eu institutions is essential in order to ensure the eu’s leadership and increase the effectiveness of its efforts to implement the 2030 agenda;


### 9. recalls that voluntary national reviews are the cornerstone of the follow-up and review framework for the 2030 agenda and a key accountability tool; welcomes the commission’s initiative to draft and present the first eu voluntary review report in 2023; ### 9. recalls that voluntary national reviews are the cornerstone of the follow-up and review framework for the 2030 agenda and a key accountability tool; welcomes the commitment of nine eu member states to present their national voluntary review at the 2023 hlpf and invites all member states to engage in this process in the following years; emphasizes that voluntary national reviews can only serve the purpose of providing accountability if they are done in an objective manner that focuses on shortcomings as much as on achievements;


### 11. underlines the importance of enhanced cooperation with partners in the global south , particularly the african union and civil society representatives , in order to implement the 2030 agenda globally; ### 11. underlines the importance of enhanced cooperation with partners in the global south , particularly the african union and civil society representatives , in order to implement the 2030 agenda globally; notes that its implementation will enable partner countries to achieve their own development goals (e.g. the au agenda 2063) and their self-reliance on the path to a just and equal society; stresses in this context that the universality of the sdgs as a common agenda represents an opportunity to restore trust and position the eu as a bridge builder between the global north and the global south;


### 12. stresses , in this regard , that the eu and its member states must avoid negative spillover effects at the expense of the global south , which occur as a result of their past economic and technological model; advocates cooperation with global partners to turn any negative spillover effects into virtuous circles; calls for all eu policies to be subject to a mandatory sdg check to provide more insight on and address any negative effects and ensure that change in this area is measurable; ### 12. stresses , in this regard , that the eu and its member states must avoid negative spillover effects at the expense of the global south , which undermine their efforts to achieve the sdgs and which occur as a result of the member states’ past economic and technological model; advocates cooperation with global partners to turn any negative spillover effects into virtuous circles; calls for all eu policies to be subject to a mandatory sdg check to provide more insight on and address any negative effects and ensure that change in this area is measurable; welcomes the recent agreement reached between the co-legislators on the deforestation regulation , which will ensure that products circulated in the eu market will no longer contribute to deforestation and forest degradation in other parts of the world; reiterates its calls on the commission and on the council to take the actions listed in its recent resolution on policy coherence for development so as to make the implementation of this principle effective;


### 13. points out that , in order to assess the member states’ progress on the sdgs , the eurostat sustainable development indicators must be improved by filling the gaps for some sdgs and better measuring policies’ impact on territories and specific vulnerable groups; ### 13. reiterates its support for the work of eurostat in relation to the sdgs monitoring in the eu; points out that , in order to assess the member states’ progress on the sdgs , the eurostat sustainable development indicators must be improved by filling the gaps for some sdgs and better measuring policies’ cross-border and long-term distributional impact on territories and specific marginalized and vulnerable groups , in the eu and globally;


### 14. notes , furthermore , that important data remains unavailable on global , national and regional development policies in the global south , particularly with regard to the poorest and most marginalised people; ### 14. notes , furthermore , that important evidence-based data remains unavailable on global , national and regional development policies in the global south , particularly with regard to the their impact on poorest and most vulnerable and marginalised groups and territories people; highlights that accurate and reliable data is crucial to measure progress and identify bottlenecks; regrets the lack of comprehensive oda reporting per sdg by the eu and all member states; calls for strengthening and accelerating human , institutional and infrastructure data capacity building , especially in the developing countries and eu internal monitoring tools , such as the gender marker or the newly established inequality marker;


### 15. highlights the importance of voluntary local reviews and voluntary subnational reviews as a means of further localising the sdgs and therefore advancing their implementation; ### 15. highlights the importance of voluntary local reviews and voluntary subnational reviews as a means of further localising the sdgs and therefore advancing their implementation; stresses that regular comprehensive reviews of sdgs progress at sub-national and local level can reinforce vertical and horizontal coherence , stimulate local participation , facilitate peer-learning between regions and cities at global level and contribute to the overall sdg implementation; strongly supports , in this regard , the work of the joint research center on localising the sdgs inter alia through the “regions2030: monitoring the sdgs in the eu regions - filling the data gaps” project and the european handbook for sdgs voluntary local reviews; calls for a european platform for vlrs to foster exchange and learning as well as twinning approaches across europe for accelerated sdg implementation at local level; suggests that this data be integrated in the eu cohesion policies;


### 16. calls on the commission to present the ‘beyond gdp’ dashboard without delay , as set out in the 8th environment action programme; ### 16. points out that there is a growing awareness that economic growth , as measured primarily by gdp , has little to do with prosperity and well-being and that sustainability must be at the core of economic systems; regrets that no policy at eu level aims at a paradigm shift or reform of our economic systems , including the replacement of gdp growth with a measure of progress based on the well-being of people and planet as the key measure of economic performance; calls on the commission to present the ‘beyond gdp’ dashboard without delay , as set out in the 8th environment action programme;


### 18. calls for the preparation of an eu financing plan for the sdgs; underlines that the 2030 agenda should guide all eu financing tools and their programming; calls on the commission to put forward a proposal for a social taxonomy to complement the green taxonomy and help implement the european green deal; ### 18. calls for the adoption of an eu financing plan for the sdgs; underlines that the 2030 agenda should guide all eu financing tools and their programming , especially the mff , ndici-global europe , efsd+ , the eu’s main development financing tools; calls on the commission to put forward a proposal for a social taxonomy to complement the green taxonomy and help implement the european green deal;


### 19. stresses that adequate financing for the attainment of the sdgs , especially in developing countries , requires a thorough overhaul of the global financial architecture; urges the commission and the member states to step up their engagement and jointly work towards the necessary reforms of the international monetary fund , the world bank group and multilateral development banks in order to adjust these financial institutions’ visions and operating models with a focus on strengthening the fight against poverty and rising inequality and promoting a just and sustainable transition; ### 19. stresses that adequate financing for the attainment of the sdgs , especially in developing countries , requires a thorough overhaul of the global financial architecture; urges the commission and the member states to step up their engagement and jointly work towards the necessary reforms of the international monetary fund , the world bank group and multilateral development banks in order to adjust these financial institutions’ visions and operating models with a focus on strengthening the fight against poverty and rising inequality and promoting a just and sustainable transition; regrets that the structural reforms promoted by the imf and the world bank have contributed to the weakening of the ability of developing countries to promote public policies to fight poverty and to strengthen education and health systems


### 21. stresses that more than half of the world’s poorest countries face either a debt crisis or a high risk of one; welcomes the un secretary-general’s push for a global sdg stimulus package and calls for effective debt relief measures that make use of the full toolset available and include both ‘new lenders’ and private creditors; ### 21. stresses that more than half of the world’s 69 poorest countries face either a debt crisis or a high risk of one; emphasises the need both for rapid debt relief , ending the “too little , too late”1asyndrome and unnecessary aggravation of debt situations , and for systemic changes towards a rules-based multilateral order capable of preventing new debt crises;reiterates its call on the commission , in consultation with all major international actors and the countries concerned , to draw up a genuine strategy to save developing countries from excessive indebtedness;notes that the common debt framework still does not provide concrete debt reliefand calls for an enhanced multilateraldebt relief initiative with an effective mechanism to engageprivate creditors , debt relief in return for sdg achievement and climate action (debt swaps) and measures to facilitate lender coordination on new loan contracts;


### 21. stresses that more than half of the world’s poorest countries face either a debt crisis or a high risk of one; welcomes the un secretary-general’s push for a global sdg stimulus package and calls for effective debt relief measures that make use of the full toolset available and include both ‘new lenders’ and private creditors; ### 21. stresses that more than half of the world’s poorest countries face either a debt crisis or a high risk of one; welcomes the un secretary-general’s push for a global sdg stimulus package and calls for effective debt relief measures that make use of the full toolset available and include both ‘new lenders’ and private creditors; calls on the eu and its member states to support global debt relief efforts for developing countries , and to consider a full debt cancellation.


### 24. instructs its president to forward this resolution to the council and the commission. ### 24. instructs its president to forward this resolution to the council and the commission as well as to the secretary general of the united nations and the president of the united nations general assembly .


### 13. emphasises the role of a healthy diet in cancer prevention and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of harmonised , mandatory front-of-pack nutrition labelling , such as the nutri-score; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , trans-fats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media; ### 13. emphasises the role of a healthy diet in cancer prevention , in particular the mediterranean diet , and that individual cancer risks can be reduced by an appropriate intake of fruits and vegetables , and therefore welcomes the upcoming revision of the ‘eu school fruit , vegetables and milk scheme’; asks the commission and the member states to help consumers to make informed , healthy and sustainable choices about food products via the adoption of harmonised , mandatory front-of-pack nutrition labelling , such as the nutri-score; welcomes the focus on healthy nutrition in the eu child guarantee15 and calls for a new eu action plan on childhood obesity; supports fiscal measures to make fresh foods (such as pulses , grains and vegetables) more affordable and accessible at national level , especially for people with low incomes; takes the view that access to higher-quality food products is facilitated by short marketing channels , which should provide real support for small and medium-sized agricultural producers , who follow more sustainable practices , ensuring fair prices for production , a stable and decent income for farmers and food sovereignty for every state; encourages member states to use pricing policies , such as value added tax differentiation , and marketing controls to influence demand for , access to and the affordability of food and drink low in saturated fats , trans-fats , salt and sugar; supports member states in restricting the advertising of ultra-processed food products and sugary and sweetened beverages , including on social media;


### 19. looks forward to the implementation of the revised drinking water directive19 and the implementation and enforcement of the water framework directive20 , which will reduce the concentrations in surface and ground waters of certain pollutants that could contribute to cancer incidence; ### 19. looks forward to the implementation of the revised drinking water directive19 and the implementation and enforcement of the water framework directive20 , which will reduce the concentrations in surface and ground waters of certain pollutants that could contribute to cancer incidence; takes the view that the right to water is a universal right and that if everyone is to be guaranteed that right and able to access water that is high quality , water (and sanitation) services must remain public;


### 21. considers that the next review of the european code against cancer (ecac) will have to take into account the latest knowledge on environmental carcinogens; calls for the regulation on food contact materials22 to be reviewed in order to reduce exposure to carcinogens and endocrine disruptors; ### 21. considers that the next review of the european code against cancer (ecac) will have to take into account the latest knowledge on environmental carcinogens; calls for the regulation on food contact materials22 to be reviewed in order to reduce exposure to carcinogens and endocrine disruptors; the next review of ecac should be coordinated by the international agency for research on cancer and it should support a systematic evaluation of the code , including greater clarity as to how the ambition to achieve 80 % awareness of the ecac’s messages will be measured;


### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs; ### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu and that 8% of all cancer cases are work-related , making up 12% of cancer cases among men and 7% of cancer cases among women; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; stresses that 50 priority carcinogens have been identified and that workers are widely exposed to them in europe , but that binding occupational exposure limit values exist to date for only 27 of them; calls for the scope of the carcinogens and mutagens directive (directive 2004/37/ec - cmd) to be extended to include substances toxic to reproduction and dangerous medicines and for a new coherent , transparent and risk-based system for setting exposure limits to be established; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs;


### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work23 , and the addition of further binding occupational exposure limits within that directive; welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs; ### 22. recalls that exposure at work is responsible for at least 120 000 deaths from cancer each year in the eu; looks forward to the forthcoming new eu strategic framework on health and safety at work for the 2021-2027 period and the close and regular involvement of stakeholders in this , the regular update of directive 2004/37/ec of 29 april 2004 on the protection of workers from the risks related to exposure to carcinogens or mutagens at work , and the addition of further binding occupational exposure limits within that directive , including exposure to hazardous drugs (e.g. for healthcare professionals) and to uv radiation (e.g. for outdoor workers); welcomes the commission’s commitment to presenting a legislative proposal to further reduce workers’ exposure to asbestos in 2022; asks member states to facilitate recognition of and compensation for proven work-related cancers; stresses the need to ensure the best possible general and individual protection measures for healthcare workers handling anti-cancer drugs;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical , vaginal , vulvar , penile , anal and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; subject to localized context-specific evaluations; calls for improving the uptake of hpv vaccination in line with the who global strategy on the elimination of cervical cancer encompassing vaccination but also screening , access to treatment , and rehabilitation; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination , encourages the regular monitoring of current hpv and hepatitis b vaccination at european level; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy;


### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states to ensure the elimination of all hpv-related cancers; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy; ### 23. encourages the commission and the member states to promote the prevention of cancers related to infectious diseases; recalls that human papillomavirus (hpv) is a sexually transmitted infection associated with uterine , cervical and oropharyngeal cancers; welcomes the vaccination programmes in the fight against hpv transmission; notes and regrets major discrepancies in vaccination coverage between member states , ranging from less than 30 % to more than 70 % (with the required level of population immunity being at 70 %); insists that a gender-neutral hpv vaccination programme be implemented in the member states , subject to localized context-specific evaluations , to ensure the elimination of all hpv-related cancers; calls for improving the uptake of hpv vaccination in line with the who global strategy on the elimination of cervical cancer encompassing prevention , educational programs , vaccination as well as screening , access to treatment and rehabilitation; considers it important to draw up further recommendations to better implement these programmes; calls for more harmonisation of hpv and hepatitis b vaccination within member states’ national programmes , while ensuring the provision of information about and equal access to vaccination; supports further research into the most effective vaccination schedules against other carcinogenic viruses such as hepatitis c; calls for collaboration with member states and international organisations to combat the impact of misinformation on vaccination and address vaccine hesitancy;


### 27. encourages the commission and the member states to promote health literacy as regards cancer risks and determinants , to develop educational tools for prevention and to support the creation of e-learning platforms and applications; considers cancer prevention to be a first step towards a european public health education policy; ### 27. encourages the commission and the member states to promote health literacy as regards cancer risks and determinants , to develop educational tools for prevention and to support the creation of e-learning platforms and applications; considers cancer prevention to be a first step towards a european public health education policy and highlights that particular attention should be paid to disadvantaged , vulnerable , socially excluded , and marginalized people; calls for the use of all available prevention tools including alternative reduced risk tools , alcohol-prevention strategies , and nutritional campaigns;


### 29. underlines that tobacco and alcohol consumption , poor nutrition , a high body mass index and a sedentary lifestyle are risk factors common to other chronic diseases; believes , therefore , that cancer prevention has to be implemented in the context of an integrated chronic disease prevention programme , in close cooperation with the steering group on health promotion , disease prevention and management of non-communicable diseases; ### 29. underlines that tobacco , harmful alcohol consumption , poor nutrition , a high body mass index and a sedentary lifestyle are risk factors common to other chronic diseases; believes , therefore , that cancer prevention has to be implemented in the context of an integrated chronic disease prevention programme , in close cooperation with the steering group on health promotion , disease prevention and management of non-communicable diseases;


### 31. deplores the frequent delays to cancer diagnosis related to a lack of information or adherence to cancer screening and detection processes; recognises the need to pay particular attention to the continuity of screening programmes and early detection in the context of a health crisis (such as the covid-19 crisis); ### 31. deplores the frequent delays to cancer diagnosis related to a lack of information or adherence to cancer screening and detection processes; recognises the need to pay particular attention to the continuity of screening programmes and early detection in the context of a health crisis (such as the covid-19 crisis); considers that stepping up public health services (including financial aspects , infrastructure and aspects involving health professionals) is key to increasing and speeding up cancer prevention , screening and diagnosis;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; calls for the inclusion of lung cancer screening of the high-risk population in the upcoming cancer screening scheme according to the latest scientific evidence; and calls for the establishment of a permanent platform to enable the networking of cancer screening programme coordinators , facilitate the training and capacity-building for improving quality in screening programmes , act as central hub for projects and initiatives on cancer supported by the eu , and maintain in the long term the network of data providers to the implementation report by the iarc on cancer screening in the european union;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025 and calls for the establishment of a permanent platform to enable the networking of cancer screening programme coordinators , facilitate the training and capacity-building for improving quality in screening programmes , act as central hub for projects and initiatives on cancer screening supported by the eu , and maintain in the long term the network of data providers to the implementation report by the iarc on cancer screening in the european union;


### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; ### 34. supports the launch of a new eu-supported cancer screening scheme , as announced in europe’s beating cancer plan , to help member states to ensure that 90 % of the eu population who qualify for breast , cervical and colorectal cancer screenings are offered screening by 2025; urges the commission to take measures for monitoring and regular reporting via the cancer inequalities registry towards the achievement of this goal;


### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states roll out programmes for early clinical detection of oral and skin cancers; ### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; encourages the commission and the member states to promote targeted screening for high-risk groups such as hereditary breast cancer , based on the available evidence; recommends that member states roll out programmes for early clinical detection of oral and skin cancers;


### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states roll out programmes for early clinical detection of oral and skin cancers; ### 35. encourages member states to promote cancer screening for breast , cervical and colorectal cancers as part of organised population-based national and regional programmes , including in the remote and outermost regions , and provide adequate resources; recommends that member states introduce research programs , investigate quality assured public health programmes for early clinical detection of oral and skin cancers and implement evidence-based treatment guidelines;


### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation; ### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls to recognise the extensive body of evidence that proves the positive effect of targeted lung cancer screening; encourages the council to include lung and prostate cancer screening in the update of the council recommendations in 2022; calls the council to mandate the commission to develop eu guidelines;


### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation; ### 38. welcomes the upcoming update of the 2003 council recommendation on breast , cervical and colorectal cancer screening24 to take into account new screening tests and the most recent data on the best screening protocols (magnetic resonance imaging , hpv testing); calls for lung cancer screening guidelines in line with the most recent scientific evidence; emphasises that those programmes should be regularly evaluated by the competent national authorities; calls for research efforts to be fostered in order to assess , in close cooperation with the iarc and the who , the possible inclusion of new science-based cancer screening programmes (including lung , prostate , stomach and ovarian cancers) in the recommendation;


### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns; ### 40. stresses the importance of increasing awareness about , and the uptake of , cancer screening and early detection among eu citizens via union-wide awareness campaigns , european awareness days , motivation surveys and better implementation of existing communication campaigns; encourages research into behavioural adherence factors to boost participation in screening programmes , supported by european funding such as the horizon europe research programme;


### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns; ### 40. stresses the importance of increasing the uptake of cancer screening and early detection among eu citizens through european awareness days , motivation surveys and better implementation of existing communication campaigns with special attention to balanced information on advantages and disadvantages;


### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; ### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; this can mark an important contribution by the eu towards the achievement of international goals in cancer , such as the who goal for the elimination of cervical cancer as a public health problem;


### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries; ### 41. calls for reinforced cooperation with third countries to encourage the organisation of screening campaigns , in particular for women’s cancers and notably in low- and middle-income countries and with minority communities.


### 42. deplores the fact that eu patients still face challenges in accessing healthcare services in other member states and that only a minority of patients are aware of their right to seek cross-border healthcare; emphasises the need for better implementation of , and an improved financial model for , the cross-border healthcare directive25 to allow for mobility and access to highly specialised equipment and care through the reinforcement of the national contact points (ncps) by providing them with more budgetary resources , and calls for an increase in the number of information campaigns on patients’ rights to cross-border healthcare; emphasises the need to facilitate the process , through the revision of the cross-border healthcare directive , for patients who travel abroad for clinical trials and face issues such as a lack of clarity on follow-up protocols after their return home and on coverage of costs related to their clinical trial participation by national insurance agencies; calls on the commission and the member states to work together to conduct regular evaluations of the commission’s ehealth strategy from 2018 to ensure interconnected electronic health records for cancer patients at regional , national and european level; ### 42. deplores the fact that eu patients still face challenges in accessing healthcare services in other member states and that only a minority of patients are aware of their right to seek cross-border healthcare; emphasises the need for better implementation of , and an improved financial model for , the cross-border healthcare directive25 to allow for mobility and access to highly specialised equipment and care through the reinforcement of the national contact points (ncps) by providing them with more budgetary resources , and calls for an increase in the number of information campaigns on patients’ rights to cross-border healthcare; emphasises the need to facilitate the process , through the revision of the cross-border healthcare directive , for patients who travel abroad for clinical trials and face issues such as a lack of clarity on follow-up protocols after their return home and on coverage of costs related to their clinical trial participation by national insurance agencies; calls on the commission and the member states to work together to conduct regular evaluations of the commission’s ehealth strategy from 2018 to ensure interconnected electronic health records for cancer patients at regional , national and european level; notes the potential of the cancer inequalities registry as a means of reporting and measuring improvement on these concerns;


### 44. calls for full recognition of medical oncology as a specialist discipline , the establishment of pan-european quality standards for administering and supervising medical treatments for cancer , and the facilitation of patients’ access to cancer specialists so that they may benefit from innovations and access to early clinical trials on new promising drugs; ### 44. calls for full recognition of medical oncology as a specialist discipline , the establishment of pan-european quality standards for administering and supervising medical treatments for cancer , and the facilitation of patients’ access to cancer specialists so that they may benefit from innovations and access to early clinical trials on new promising health technologies;


### 46. supports the improvement of high-quality radiation therapy in the eu through the recognition of medical physics and radiation therapy as dedicated disciplines , the promotion of common education and training standards , and the greater investment of eu and national research and innovation funds in radiation therapy research; ### 46. supports the improvement of , and an increased access to , high-quality radiation therapy in the eu through the recognition of medical physics and radiation therapy as dedicated disciplines , the promotion of common education and training standards , increased funding for member states to expand their radiation therapy infrastructure , and the greater investment of eu and national research and innovation funds in radiation therapy research;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary care teams (mdt) to manage cancer patients throughout their treatment journey; stresses that mdts should include a specialised oncology nutritionist or dietician , given the high prevalence and impact of nutritional issues from diagnosis through to end-of-life;


### 48. calls on the commission to promote , and on member states to strengthen , the role of general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists; ### 48. calls on the commission to promote , and on member states to strengthen , the role of family doctors , general practitioners , paediatricians and primary care professionals , given their importance in patient referral to diagnostic tests and oncology specialists , as well as during cancer treatment and follow-up care; calls for the development of multidisciplinary decision-making in the framework of dedicated concertation meetings bringing together various cancer specialists;


### 50. calls on the member states to take preventive measures against the risk of burnout among cancer care professionals; ### 50. calls on the member states to develop , within their national cancer control plans , strategies that encompass and implement preventive measures against the risk of burnout among cancer care professionals;


### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; ### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care outside hospital;


### 51. encourages , where possible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care; ### 51. encourages , where feasible and safe , the use of ambulatory cancer treatments in order to preserve the quality of life of patients; calls on member states to implement or improve e-health technologies and telemedicine services to ensure the continuity of cancer care outside hospital and in the community;


### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; ### 52. calls on the member states to provide , within their national cancer control plans , optimal relief for advanced-stage cancer patients in order to ease their pain and discomfort at the end of their lives- while preserving their dignity and taking into account the autonomy of the patient and his or hers needs; calls on the commission to support and coordinate regular exchange of information and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources;


### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources; ### 52. calls on the member states to provide optimal relief for advanced-stage cancer patients at the end of their lives in order to ease their pain and discomfort while preserving their dignity; supports more intensive exchanges and the implementation of best practices on hospice and palliative care at eu level; encourages member states to assess the number of palliative units in each region and to ensure sustainable funding and sufficient and well-trained human resources , and to create a network of public facilities that provides this response;


### 53. encourages the commission and the member states to adopt specific quality assurance criteria (including adequate organisations , infrastructures and competences , multidisciplinary practice , continuing education for professionals , patient education and participation in clinical research) for accreditation standards to be applied to public and private hospitals treating cancer patients , in order to ensure the efficient , safe and equal management of cancers all over the eu; ### 53. encourages the commission and the member states to adopt within the national comprehensive cancer centers , national cancer strategies and policies specific quality assurance criteria (including adequate organisations , infrastructures and competences , multidisciplinary practice , continuing education for professionals , patient education and participation in clinical research) for accreditation standards to be applied to public and private hospitals treating cancer patients , in order to ensure the efficient , safe and equal management of cancers all over the eu;


### 54. welcomes the planned establishment , as announced in europe’s beating cancer plan , of an eu network linking recognised national comprehensive cancer centres (reference centres) in every member state to facilitate the uptake of quality-assured diagnosis and treatments , including training , research and promotion of clinical trials across the eu; calls on the commission to identify such existing centres within the eu , to promote the establishment of at least one comprehensive cancer centre in each member state and to support the coordination of the network of these centres via a european cancer institute; ### 54. welcomes the planned establishment , as announced in europe’s beating cancer plan , of an eu network linking recognised national comprehensive cancer centres (reference centres) in every member state to facilitate the uptake of quality-assured diagnosis and treatments , including training , research and promotion of clinical trials across the eu; calls on the commission to identify such existing centres within the eu , to promote the establishment of at least one comprehensive cancer centre in each member state and to support the coordination of the network of these centres via a european cancer institute; calls on the european commission and the members states to support the sustainability of pre-existing cross-border collaborations , such as in the paediatric cancer sector , and the european reference networks; recommends the implementation and enforcement of multi-disciplinary collaboration the soonest possible to improve the quality of care for patients; considers that cancer specialties and medical disciplines should be involved from the start in the work of the envisioned eu network of national comprehensive cancer centres;


### 55. calls for the identification , reinforcement or creation in each member state of a national cancer control programme (nccp) , consisting of a unique structure , possibly a national cancer institute , in charge of the implementation and follow-up of the respective nccps , with adequate objectives and resources; recommends that the nccps are set up in coherence with the european guide for quality national cancer control programmes initiated by the european partnership for action against cancer (epaac); welcomes the setting up of a network of these organisations coordinated by the european cancer institute; ### 55. calls for the identification , reinforcement or creation in each member state of a national cancer institute in charge of the implementation and follow-up of the respective national cancer strategy (ncs); stresses that , for this purpose , clear objectives should be set accompanied by adequate resources and management; recommends that the ncss are set up in coherence with the european guide for quality national cancer control programmes initiated by the european partnership for action against cancer (epaac); welcomes the setting up of a network of these organisations coordinated by the association of european cancer institutes;


### iii.b. equal access to cancer care: towards a european medicines market ### iii.b. equal access to cancer care


### 56. calls on the commission to strengthen the european medicines market in order to guarantee equal access to treatment , reduce medicine shortages , overcome the problem of high prices for innovative treatments , and improve cancer treatments for adults and children; ### 56. calls on the commission and antitrust authorities to assess and defend the european medicines market keeping the attention on the acquisition of smes by large pharmaceutical companies that undermine fair competition;


### 56. calls on the commission to strengthen the european medicines market in order to guarantee equal access to treatment , reduce medicine shortages , overcome the problem of high prices for innovative treatments , and improve cancer treatments for adults and children; ### 56. calls on the commission to evaluate and form the european medicines market in order to guarantee equal access to treatment , reduce medicine shortages , overcome the problem of high prices for innovative treatments , improve cancer treatments for adults and children , and thus ensuring health as a human right and a public good for all;


### 58. notes that cancer patients are frequently affected by medicine shortages; calls on the commission to present a specific strategy for managing shortages of all medicines and medical products in europe and of cancer medicines in particular; supports the development of a common basket of the cancer drugs of which there may be shortages to ensure that patients have continuous access to appropriate treatment; ### 58. notes that cancer patients are frequently affected by medicine shortages or high medicine costs; calls on the commission and the member states to work together to counter shortages of all medicines and medical products in every country and of cancer medicines in particular , which will require every state to build their research , development and production capacity for medicines and other medical products , thus safeguarding their national sovereignty in this area; considers that any development of a common basket of the cancer drugs , within the framework of cooperation among member states , of which there may be shortages to ensure that patients have continuous access to appropriate treatment must not undermine the autonomy or sovereignty of every member state in their consolidation of their own reserve in line with their needs and interests or their development of capacity in the production of medicines and other medical products;


### 59. calls for the reinforcement and diversification of the supply chain , in particular that of cancer drugs , within the eu , close monitoring of medicine tensions and shortages , and the creation of a strategic stockpile of such medicines; ### 59. calls for the reinforcement and diversification of the member states’ supply chain , in particular that of cancer drugs , close monitoring of medicine tensions and shortages , and the creation of a strategic stockpile of such medicines;


### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed; ### 60. points out that generic and biosimilar medicines enable efficient and safe cancer care , increased competition and savings for healthcare systems , thus helping to improve access to medicines for patients; stresses that their market entry should not be hampered or delayed because of unfair business strategies; urges for removing barriers to uptake and foster biosimilar medicines competition by designing policies that create a healthy long-term competition and promote biosimilar medicines use in the eu and national cancer strategies to ignite competition;


### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments; ### 61. considers that member states should converge on the evaluation of medical technologies to support access to innovative cancer diagnosis and treatments;


### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments; ### 61. considers that member states should converge on the evaluation of medical technologies; welcomes , therefore , the provisional agreement on the health technology assessment (hta) regulation reached by the european parliament and the council on 22 june 202128 to support harmonised access to innovative cancer diagnosis and treatments; calls for the mandatory involvement of hta experts in the design of clinical trials used for marketing authorization application;


### 62. insists on the need to ensure equal access to affordable drugs , in particular cancer drugs , within the eu; calls for collective negotiation on the price of medicines with pharmaceutical industries , as per the beneluxa initiative on pharmaceutical policy and the valetta declaration; considers that pharmaceutical companies should respect conditionalities on charging an affordable price for medicines developed in the framework of publicly funded research; ### 62. insists on the need to ensure equal access to affordable drugs , in particular cancer drugs , within the eu; calls for collective negotiation on the price of medicines with pharmaceutical industries , as per the beneluxa initiative on pharmaceutical policy and the valetta declaration; considers that pharmaceutical companies should respect conditionalities on charging an affordable price for medicines developed , in particular with the support of public funding; ;


### 66. notes that huge advances in biology have revealed that cancer is an umbrella term for more than 200 diseases , and that precision or personalised medicine can be made available through the drug targeting of various mutations; considers that precision or personalised medicine , consisting of a treatment choice based on individual tumour biomarkers , is a promising way to improve cancer treatment; encourages member states , therefore , to promote the implementation of regional molecular genetics platforms and facilitate equal and rapid access to personalised treatment for patients; ### 66. notes that huge advances in biology have revealed that cancer is an umbrella term for more than 200 diseases , and that precision or personalised medicine can be made available through the drug targeting of various mutations; considers that precision or personalised medicine , consisting of a treatment choice based on individual tumour biomarkers , is a promising way to improve cancer treatment; encourages member states , therefore , to promote the implementation of regional molecular genetics platforms and facilitate equal and rapid access to personalised treatment for patients in respect of data privacy and ensuring that patients are informed and consent to the use of their health data for research and market purposes;


### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials carried out in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life; ### 67. calls for the full and rapid application of regulation (eu) no 536/2014 of 16 april 2014 on clinical trials on medicinal products for human use31 ; considers that the application of the regulation would facilitate the launch of large clinical trials across europe carried out in a harmonised , efficient and coordinated manner at european level in order to facilitate research into cancer drugs and improve cancer patients’ and their families’ quality of life;


### 69. supports the development of clinical trials on the use of new cancer drugs in adults and children; ### 69. supports the development of clinical trials for the discovery of improved forms of treatment and care for patients , including children and older patients;


### 69. supports the development of clinical trials on the use of new cancer drugs in adults and children; ### 69. supports the development of clinical trials and research across europe on the use of new cancer drugs in adults and children;


### 70. welcomes the commission’s intention to adopt a legislative proposal to establish a health emergency preparedness and response authority (hera) in order to anticipate , incentivise , co-develop and facilitate rapid , equal and sustainable access to cancer innovations for cancer patients; calls for a large consortium of public authorities , private companies and ngos , including patient associations , to work together to guarantee the accessibility and affordability of cancer treatment options requiring complex technologies , for instance , cellular therapy (car t cells) , adoptive immunotherapy through the use of tumour genome extracts (messenger rna) and nanotechnologies; ### deleted


### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays in screening , referral and surgical procedures , treatment postponement , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and reduced communication with health professionals; ### 71. underlines that the covid-19 crisis has had , and is still having , a significant impact on cancer patients’ survival and quality of life at all stages of the disease , due to delays and postponements of prevention schemes , clinical trials , screenings , referral and surgical procedures , treatment , shortages in the supply of medicines and other medical supplies , specialised workforce shortages and poor communication among health professionals of different categories;


### 72. considers that the covid-19 pandemic was a real stress test for the eu’s health systems; underlines that the main lesson learned should be the need to build an emergency strategy to allow member states to react accordingly in times of any future health crises; stresses that specific measures under this emergency strategy should be aimed at the protection of vulnerable groups , including cancer patients; ### 72. considers that the covid-19 pandemic was a real stress test for the eu’s health systems; underlines that the main lesson learned should be the need to invest in public health sector and build an emergency strategy to allow member states to react simultaneously against any future health crises; stresses that specific measures under this emergency strategy should be aimed at the protection of vulnerable groups , including cancer patients , and the protection of health as a human right and a public good;


### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing health workforce shortages; acknowledges the urgency of ensuring a sufficient number of specialised health professionals in cancer care; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; ### 73. notes with concern that the covid-19 pandemic has exacerbated pre-existing workforce shortages of the public health sector; acknowledges the urgency of ensuring a sufficient number of specialised health professionals especially in public healthcare systems; reiterates that specific measures under the emergency strategy should be aimed at addressing workforce shortages through the recruitment of health professionals; underlines that new approaches for human-centred healthcare are required in order to ensure access to diagnostics , therapeutics and quality public health services for all;


### 74. advocates the development of a digital health system to monitor symptoms and ensure cancer treatment and care at home; calls for permanent access to medical consultations and psychosocial services to be guaranteed through the use of telemedicine or in health threat-free environments in hospitals; ### 74. advocates the development of a digital health system to monitor symptoms and ensure cancer treatment and care outside hospital; calls for permanent access to medical consultations and psychosocial services to be guaranteed through the use of telemedicine or in health threat-free environments in hospitals;


### 75. asks for enhanced communication between health professionals , patients and public authorities regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , and for increased awareness campaigns in times of crises; ### 75. asks for enhanced communication between health professionals , parents , caregivers , patients , survivors , public authorities , and society regarding the effectiveness and safety of health interventions , in particular cancer screening , diagnosis and treatment , and for increased awareness campaigns in times of crises;


### 76. calls on the commission and the member states to adopt european prevention and management plans to address cancer drug shortages in times of health crises; ### 76. calls on the commission and the member states to adopt european prevention and management guidelines and enforce transparency over the supply and provision of cancer drug shortages in times of health crises;


### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination; ### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); notes that there is a need to focus on the quality of life for a rising number of chronic cancer patients whose illness cannot be cured but which may be stabilised for a number of years; asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination;


### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination; ### 78. emphasises the importance of specific eu recommendations to improve the quality of life of patients , including via supportive care (pain relief , psychological services , adapted physical activity , nutritional support , social assistance , access to reproductive health and restoration of aesthetic integrity); asks member states for recognition of sequelae (physical or mental disabilities) , as well as social discrimination , including in the workplaces;